ZIPEXOLE pramipexole dihydrochloride 0.25 mg tablets blister pack

Nchi: Australia

Lugha: Kiingereza

Chanzo: Department of Health (Therapeutic Goods Administration)

Viambatanisho vya kazi:

pramipexole dihydrochloride monohydrate, Quantity: 0.25 mg

Inapatikana kutoka:

Arrotex Pharmaceuticals Pty Ltd

INN (Jina la Kimataifa):

pramipexole dihydrochloride monohydrate

Dawa fomu:

Tablet, uncoated

Tungo:

Excipient Ingredients: povidone; pregelatinised maize starch; magnesium stearate; mannitol; silicon dioxide

Njia ya uendeshaji:

Oral

Vitengo katika mfuko:

10, 30, 100

Dawa ya aina:

(S4) Prescription Only Medicine

Matibabu dalili:

Pramipexole tablets are indicated for:,-the treatment of signs and symptoms of idiopathic Parkinson's disease. It may be used as monotherapy or in combination with levodopa.,-the symptomatic treatment of primary Restless Legs Syndrome.

Bidhaa muhtasari:

Visual Identification: White, oval, uncoated tablets debossed with 'CL' and '3' on one side with breakline in between and a breakline on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Idhini hali ya:

Licence status A

Idhini ya tarehe:

2014-09-23